Catalent

Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad, deep-scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred Contract Development and Manufacturing Organization (CDMO) partner for personalized medicines, blockbuster drugs and consumer health brand extensions. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply over 80 billion doses of nearly 8,000 products annually. Its rapidly growing expert workforce exceeds 18,000, including more than 3,000 scientists and technicians. Headquartered in Somerset, New Jersey, Catalent, Inc. (NYSE:CTLT), is in S&P 500® company, and generated nearly $5 billion in revenue in its 2022 fiscal year.

Sites

Catalent Italy S.p.A

Country

Italy

City

Aprilia

Address

Via Nettunense Km.20,100, 04011

Gold

2024 Qualifyze Quality Compliance Rating2024 Qualifyze QCR

Learn more about it

Catalent Italy S.p.A

Audited

Country

Italy

City

Aprilia

Address

Via Nettunense Km.20,100, 04011

Catalent Japan K.K.

Country

Japan

City

Kakegawa

Catalent Belgium S.A.

Country

Belgium

City

Brussels

Address

Font Saint Landry 10, 1120

Catalent France Beinheim SA

Country

France

City

Beinheim

Address

Rue Principale 74, 67930

Show more